Literature DB >> 2162304

Activation of adenylate cyclase by islet amyloid polypeptide with COOH-terminal amide via calcitonin gene-related peptide receptors on rat liver plasma membranes.

T Morishita1, A Yamaguchi, T Fujita, T Chiba.   

Abstract

Both human and rat islet amyloid polypeptide with COOH-terminal amide (IAPP-NH2) dose-dependently displaced the specific binding of 125I-labeled [Tyr0] rat alpha-calcitonin gene-related peptide (CGRP) to rat liver plasma membranes, whereas human IAPP (IAPP-COOH) had no effect. Conversely, human or rat IAPP-NH2 but not human IAPP-COOH evoked dose-dependent activation of adenylate cyclase in the membranes, and these effects were significantly inhibited by the CGRP-receptor antagonist human CGRP-1(8-37). Moreover, the dose of human or rat IAPP-NH2 necessary for producing half-maximal activation of adenylate cyclase was comparable with that for producing a half-maximal inhibition of the label binding. Thus, IAPP-NH2 but not IAPP-COOH appears to induce adenylate cyclase activation via CGRP receptors on rat liver plasma membranes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2162304     DOI: 10.2337/diabetes.39.7.875

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

Review 1.  Islet amyloid polypeptide--a novel controversy in diabetes research.

Authors:  P Westermark; K H Johnson; T D O'Brien; C Betsholtz
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

2.  Cross-reactivity of amylin with calcitonin-gene-related peptide binding sites in rat liver and skeletal muscle membranes.

Authors:  A Chantry; B Leighton; A J Day
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

3.  Inhibition of insulin secretion, but normal peripheral insulin sensitivity, in a patient with a malignant endocrine pancreatic tumour producing high amounts of an islet amyloid polypeptide-like molecule.

Authors:  M Stridsberg; C Berne; S Sandler; E Wilander; K Oberg
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

4.  Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humans.

Authors:  J P Wilding; N Khandan-Nia; W M Bennet; S G Gilbey; J Beacham; M A Ghatei; S R Bloom
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

5.  A mnemonical or negative-co-operativity model for the activation of adenylate cyclase by a common G-protein-coupled calcitonin-gene-related neuropeptide (CGRP)/amylin receptor.

Authors:  M Bushfield; A Savage; N J Morris; M D Houslay
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

6.  Amylin impairment of insulin effects on glycogen synthesis and phosphoenolpyruvate carboxykinase gene expression in rat primary cultured hepatocytes.

Authors:  S Baqué; J J Guinovart; A M Gómez-Foix
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

7.  Pharmacological characterization of a receptor for calcitonin gene-related peptide on rat, L6 myocytes.

Authors:  D R Poyner; D P Andrew; D Brown; C Bose; M R Hanley
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

8.  Effects of islet amyloid polypeptide on hepatic insulin resistance and glucose production in the isolated perfused rat liver.

Authors:  M Roden; K Liener; C Fürnsinn; P Nowotny; U Hollenstein; H Vierhapper; W Waldhäusl
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.